Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study
Dinh TS, Brueckle M-S, Gonzalez-Gonzalez AI, Witte J, van den Akker M, Gerlach FM, Muth C (2022)
Journal of Personalized Medicine 12(7): 1115.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
![Open access file OA](https://pub.uni-bielefeld.de/images/access_open.png)
Autor*in
Dinh, Truc Sophia;
Brueckle, Maria-Sophie;
Gonzalez-Gonzalez, Ana Isabel;
Witte, JulianUniBi;
van den Akker, Marjan;
Gerlach, Ferdinand M;
Muth, ChristianeUniBi
Einrichtung
Abstract / Bemerkung
Structured management programs have been developed for single diseases but rarely for patients with multiple medications. We conducted a qualitative study to investigate the views of stakeholders on the development and implementation of a polypharmacy management program in Germany. Overall, we interviewed ten experts in the fields of health policy and clinical practice. Using content analysis, we identified inclusion criteria for the selection of suitable patients, the individual elements that should make up such a program, healthcare providers and stakeholders that should be involved, and factors that may support or hinder the program's implementation. All stakeholders were well aware of polypharmacy-related risks and challenges, as well as the urgent need for change. Intervention strategies should address all levels of care and include all concerned patients, caregivers, healthcare providers and stakeholders, and involved parties should agree on a joint approach.
Erscheinungsjahr
2022
Zeitschriftentitel
Journal of Personalized Medicine
Band
12
Ausgabe
7
Art.-Nr.
1115
Urheberrecht / Lizenzen
eISSN
2075-4426
Page URI
https://pub.uni-bielefeld.de/record/2964762
Zitieren
Dinh TS, Brueckle M-S, Gonzalez-Gonzalez AI, et al. Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine . 2022;12(7): 1115.
Dinh, T. S., Brueckle, M. - S., Gonzalez-Gonzalez, A. I., Witte, J., van den Akker, M., Gerlach, F. M., & Muth, C. (2022). Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine , 12(7), 1115. https://doi.org/10.3390/jpm12071115
Dinh, Truc Sophia, Brueckle, Maria-Sophie, Gonzalez-Gonzalez, Ana Isabel, Witte, Julian, van den Akker, Marjan, Gerlach, Ferdinand M, and Muth, Christiane. 2022. “Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study”. Journal of Personalized Medicine 12 (7): 1115.
Dinh, T. S., Brueckle, M. - S., Gonzalez-Gonzalez, A. I., Witte, J., van den Akker, M., Gerlach, F. M., and Muth, C. (2022). Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine 12:1115.
Dinh, T.S., et al., 2022. Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine , 12(7): 1115.
T.S. Dinh, et al., “Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study”, Journal of Personalized Medicine , vol. 12, 2022, : 1115.
Dinh, T.S., Brueckle, M.-S., Gonzalez-Gonzalez, A.I., Witte, J., van den Akker, M., Gerlach, F.M., Muth, C.: Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine . 12, : 1115 (2022).
Dinh, Truc Sophia, Brueckle, Maria-Sophie, Gonzalez-Gonzalez, Ana Isabel, Witte, Julian, van den Akker, Marjan, Gerlach, Ferdinand M, and Muth, Christiane. “Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study”. Journal of Personalized Medicine 12.7 (2022): 1115.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
jpm-12-01115-v2.pdf
1.62 MB
Access Level
![Open access file OA](https://pub.uni-bielefeld.de/images/access_open.png)
Zuletzt Hochgeladen
2022-08-09T12:47:23Z
MD5 Prüfsumme
83913cd5e24510670909439cedf1b986
Link(s) zu Volltext(en)
Access Level
![Open access file OA](https://pub.uni-bielefeld.de/images/access_open.png)
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35887612
PubMed | Europe PMC
Suchen in